Search

everythinglearnresearchcommunity

for

Search:↓

A clinically suspected melanoma appeared benign under the microscope but was confirmed by specific tests and a rare mutation.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Some people with primary cicatricial alopecia also have inflammatory bowel disease, suggesting a possible connection.

The document concludes that the immune-inhibitory environment of the hair follicle may prevent melanoma development.

A woman's long-term scalp issues were diagnosed as a rare skin disorder called cutaneous Langerhans cell histiocytosis.

Thymic LCH may be underdiagnosed, so thymic ultrasound should be considered in infants with cutaneous LCH.

Moles may stop growing due to cell cooperation, not just because of individual cell aging.

Scalp melanoma is more common and easier to diagnose early in people with androgenetic alopecia due to sun damage.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Metformin and thiazolidinediones are similarly effective for PCOS, but metformin is often preferred due to fewer side effects.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

New markers and pathways have been found in skin tumors, helping better understand and diagnose them.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

New treatments and management strategies for skin conditions like melanoma and Spitz naevi were discussed at the dermatologists' meeting.

Older adults have a high rate of skin cancers like basal cell carcinoma and melanoma, mainly due to UV exposure and age.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

New treatments for skin conditions related to the sebaceous gland are being developed based on current research.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The Wnt signaling pathway is not a major factor in the development of keratoacanthoma, a type of skin tumor.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.